Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
- To determine the antiviral efficacy of ledipasvir/sofosbuvir (LDV/SOF) +/- ribavirin (RBV) in subjects with chronic HCV infection as measured by the proportion of subjects in each treatment group with sustained viral response 12 weeks after discontinuation of therapy (SVR12) - To assess the safety and tolerability of LDV/SOF +/- RBV in subjects with chronic HCV infection as measured by review of the accumulated safety data
Inclusion criteria
- Chronic hepatitis C virus infection